VTVT News and Press, vTv Therapeutics Inc. From 05/07/20

HIGH POINT, N.C., May 07, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the first quarter ended March 31, 2020, and provided an update on recent clinical achievements. “In spite of the challenges presented by the COVID-19 pande...

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

vTv Therapeutics (NASDAQ: VTVT ): Q4 Non-GAAP EPS of -$0.11; GAAP EPS of -$0.13 misses by $0.08 . Cash and cash equivalents of $1.78M Press Release More news on: vTv Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, ,

HIGH POINT, N.C., Feb. 20, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the fourth quarter and year ended December 31, 2019, and provided an update on recent clinical achievements. “Our success in enrolling and executing cli...

Today, we will see why vTv Therapeutics ( VTVT ) is a promising pick for 2020. Company overview Founded in 2015, vTv Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapies for the treatment of Alzheimer’s disease, diab...

Catalyst Biosciences Receives a Boost with Positive Study Readout Catalyst Biosciences ( CBIO ) reported that it has obtained positive results from a Phase 2b clinical trial of its Factor IX therapy. This open label study involved six patients suffering from severe hemophilia B. The daily...

YayYo (NASDAQ: YAYO ) -59%  after announcing voluntary delisting from Nasdaq. More news on: YayYo, Inc., Myomo, Inc., Co-Diagnostics, Inc., Stocks on the move, , Read more ...

Gainers: vTv Therapeutics (NASDAQ: VTVT )  +57% . More news on: vTv Therapeutics Inc., Taubman Centers, Inc., NanoViricides, Inc., Stocks on the move, , Read more ...

vTv Therapeutics (NASDAQ: VTVT ) +80%  on positive TTP399 data . More news on: vTv Therapeutics Inc., Taubman Centers, Inc., Edgewell Personal Care Company, Stocks on the move, Read more ...

Thinly traded micro cap vTv Therapeutics (NASDAQ: VTVT ) is up  21%  after hours in response to its announcement that it will release topline data from Part 2 of a Phase 2 clinical trial, Simplici-T1 , evaluating TTP399 as oral adjunctive therapy to insulin in adults with type 1...